Drugs / Dendritic Killer Cell (DKC)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02882659 | Aug 2014 → Jan 2016 | colorectal neoplasm, hepatocellular carcinoma, metastatic neoplasm | FullHope Biomedical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Killer Cell (DKC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02882659 ↗ |
| Modality | Cell therapy | “DKC cell therapy” NCT02882659 ↗ |